Conformis to Bring Furloughed Employees Back to Work

The Billerica, MA-based company said it was ending the furlough because of the $4.7 million loan it received from the Paycheck Protection Program and the anticipated relaxing of restrictions on elective surgeries.

Omar Ford

April 23, 2020

2 Min Read
MDDI logo in a gray background | MDDI

There’s some significant news coming out of Conformis today. The custom orthopedic implant company said it expects most of the 80 employees it had to furlough about a month ago will be returning to active employment as early as April 27, 2020. The company said there some employees who have separated from it in the normal course of business.

The Billerica, MA-based firm said two factors contributed to the furlough ending. The first reason is the $4.7 million loan it received from the Paycheck Protection Program administered by the U.S. Small Business Administration. These loans are offered because of the economic harm caused by the coronavirus (COVID-19) to companies. The company announced receiving the loan earlier this week.

The second reason the company cited was that the phase 1 guidelines for Opening Up America again looked highly-favorable for furloughed employees.

In a release, Conformis President and CEO Mark Augusti said, “A month ago, we announced the difficult decision to furlough a significant portion of our direct workforce in response to mandated government shutdowns of elective surgery across the globe and especially in the United States. I am very pleased to report that, because of the federal government’s CARES Act and, specifically, the PPP Loan we received, we are able to return our employees to work.”

Augsti added, “we have started to receive indications that elective surgeries in the U.S. may return slightly sooner than expected, especially in ambulatory surgical or outpatient centers, as noted by the government’s Phase 1 guidelines for ‘Opening Up America Again.’ We believe that our proprietary approach to total joint replacement is uniquely suited for efficiently handling these outpatient cases. We would note that our approach also provides for a best-in-class approach to limiting infection and reducing the exposure and burden to medical staff.”

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like